Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals sector, which has enjoyed rising valuations and solid performance. Trading under the stock code 2591, Innogen’s shares first changed hands at HK$72 on Friday, almost four times more than the initial public offering (IPO) price…
Southbound capital flowing into the Hong Kong stock market hit an all-time high in the first seven months of 2025, reflecting investor confidence in the city on the back of surging turnover and a revived pipeline of initial public offerings (IPOs). Mainland Chinese investors snapped up more Hong Kong equities so far this year than…
A media report overt the weekend saying the London Stock Exchange Group (LSEG) is considering 24-hour trading has raised questions about whether Hong Kong’s bourse could similarly lengthen its transaction hours to cater to a younger generation of trade-anytime investors. The Orion Derivatives Platform (ODP), developed by Hong Kong Exchanges and Clearing (HKEX) for roll-out…